CG:688363 Bloomage Biotechnology Corp Ltd

Bloomage BioTechnology Corporation Limited, an investment holding company, develops, manufactures, and sells bio-chemical products in China, rest of Asia, the Americas, Europe, and internationally. It offers sodium hyaluronic acid (HA) raw materials and end products for use in pharmaceutical, cosmetic, and health care products. The company's HA materials include pharmaceutical grade sodium hyaluronate under the Hyatrue name; food grade sodium hyaluronate under the HAPLEX name; cosmetic grade sodium hyaluronate under the Freda name; and Oligo HA under the Mini HA name. Its end products comprise modified sodium hyaluronic gel for injection under the BioHyalux and Dermallure names. The company also trades in HA end products and raw materials, cosmetic products, and medical devices. Bloomage BioTechnology Corporation Limited was founded in 2003 and is based in Central, Hong Kong.

139.29 CNY
As of 01/17/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Specialty Chemicals
Index country:  China
Country of incorporation:  China
IPO date:  11/06/2019
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   65,615,998,976 CNY
Current dividend yield:   0.30%
Sedol:      BKT86W8

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy